Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 8/20 | 0.42 |
| ▸ | ATR | Q13535 | 1/20 | 0.41 |
| ▸ | TNK2 | Q07912 | 2/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.38 |
| ▸ | F10 | P00742 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16168183 | 0.90 | LTA4H (0.47) | BTKLTA4HNR1H2NR1H3MCL1 | |
| SCHEMBL18800677 | 0.88 | MCL1 (0.46) | BTKMCL1XDH | |
| SCHEMBL18800806 | 0.87 | BTK (0.49) | BTKTNK2MCL1XDH | |
| SCHEMBL18800779 | 0.87 | XDH (0.47) | BTKMCL1XDH | |
| SCHEMBL18800690 | 0.86 | KDM4E (0.40) | BTKTNK2MCL1 | |
| SCHEMBL18800890 | 0.85 | TNK2 (0.48) | BTKATRTNK2ADORA2AMCL1 | |
| SCHEMBL18800613 | 0.85 | MCL1 (0.53) | BTKTNK2MCL1XDH | |
| SCHEMBL18800656 | 0.85 | BTK (0.55) | BTKADORA2AXDH | |
| SCHEMBL18800817 | 0.84 | TNK2 (0.52) | BTKTNK2F10MCL1 | |
| SCHEMBL18800649 | 0.83 | MEN1 (0.46) | BTKTNK2MCL1XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2789615-B1 | Azaindazoles as Btk kinase modulators and use thereof | BRISTOL MYERS SQUIBB CO (US) | 2017-05-03 | — | — | EP | disclosed |